Molecular Partners Presents New Data on its Radio DARPin Therapy (RDT) Platform at the EANM ...
New preclinical RDT data show that DARPins can be engineered to increase tumor uptake as well as reducing accumulation in kidneysEngineering solutions transferrable across the platform and to a broad